Enveric Biosciences Inc (ENVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 5,755 | 4,861 | 12,256 | 5,657 | 4,707 |
| Operating Income | -5,755 | -4,861 | -12,256 | -5,657 | -4,707 |
| Interest Expense | -1 | 0 | 0 | 0 | 1 |
| Other Income | -602 | 183 | 2,092 | 3,178 | 1,917 |
| Pre-tax Income | -6,356 | -4,678 | -10,164 | -2,479 | -2,791 |
| Net Income Continuous | -6,356 | -4,678 | -8,678 | -2,479 | -2,791 |
| Net Income | $-6,356 | $-4,678 | $-8,678 | $-2,479 | $-2,791 |
| EPS Basic Total Ops | -547.15 | -415.76 | -624.54 | -262.77 | -491.35 |
| EPS Basic Continuous Ops | -542.68 | -405.14 | -611.60 | -249.67 | -476.51 |
| EPS Diluted Total Ops | -547.15 | -415.76 | -624.54 | -262.77 | -491.35 |
| EPS Diluted Continuous Ops | -542.68 | -405.14 | -611.60 | -249.67 | -476.51 |
| EBITDA(a) | $-5,641 | $-4,747 | $-4,712 | $-5,536 | $-4,587 |